Find comprehensive information on Yeast Vaginitis diagnosis, including clinical documentation, medical coding (ICD-10 B37.3, Candida vaginitis), and healthcare guidelines. Learn about symptoms, treatment, and differential diagnosis for vulvovaginal candidiasis, yeast infection, and vaginal candidiasis. This resource offers support for accurate medical coding and complete clinical documentation for healthcare professionals.
Also known as
Candidal vulvovaginitis
Vaginal infection caused by Candida species.
Other superficial mycoses
Fungal infections affecting skin and mucous membranes.
Inflammatory diseases of vagina
Covers various inflammatory conditions of the vagina.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis yeast vaginitis?
Yes
Is it uncomplicated?
No
Do not code as yeast vaginitis. Review diagnosis.
When to use each related code
| Description |
|---|
| Yeast infection of the vagina |
| Bacterial Vaginosis |
| Trichomoniasis |
Using unspecified vaginitis codes (e.g., N76.0, N76.8) when yeast vaginitis is confirmed leads to inaccurate data and reimbursement.
Coding yeast vaginitis (B37.3) without documented Candida species identification via microscopy or culture lacks diagnostic specificity.
Coding recurrent yeast vaginitis (B37.3, N76.1) without proper documentation of multiple episodes within a timeframe risks overcoding and audit issues.
Q: How to differentiate Vulvovaginal Candidiasis from other causes of vulvovaginitis in clinical practice?
A: Differentiating vulvovaginal candidiasis (VVC) from other vulvovaginitis etiologies like bacterial vaginosis (BV) or trichomoniasis requires a comprehensive approach. Consider these key factors: 1. **Symptoms:** While itching is common in VVC, it can also occur in other conditions. Thick, white, "cottage cheese" discharge is more suggestive of VVC, while a thin, grayish discharge with a fishy odor points towards BV. Trichomoniasis often presents with a frothy, yellow-green discharge and may cause dysuria. 2. **Point-of-Care Testing:** Performing a vaginal pH test can be helpful. VVC typically presents with a normal vaginal pH (3.8-4.5), while BV often elevates pH above 4.5. Microscopic examination of a wet mount preparation can reveal budding yeast and pseudohyphae in VVC, clue cells in BV, and motile trichomonads in trichomoniasis. 3. **Culture:** While not always necessary, fungal culture can confirm the diagnosis of VVC and identify the specific Candida species, which is especially useful in recurrent or resistant cases. Explore how integrating these diagnostic steps can improve the accuracy of VVC diagnosis and guide appropriate treatment decisions.
Q: What are the recommended first-line antifungal treatments for uncomplicated and complicated Yeast Vaginitis, considering patient preferences and CDC guidelines?
A: For uncomplicated VVC, the CDC recommends short-course topical antifungal therapies (e.g., clotrimazole, miconazole) as the first-line treatment due to their efficacy, safety, and over-the-counter availability. Oral fluconazole (single dose) is another effective option, particularly for patients who prefer oral medication or have difficulty with topical application. For complicated VVC (e.g., recurrent infections, severe symptoms, non-albicans species), longer-duration topical or oral antifungal regimens are recommended. Consider implementing patient-centered shared decision-making to select the most appropriate treatment option, taking into account individual preferences, cost, and potential adverse effects. Learn more about the latest CDC guidelines for VVC management to ensure optimal patient care.
Subjective: Patient presents complaining of vaginal itching, burning, and irritation. She describes a thick, white, cottage cheese-like vaginal discharge. Symptoms have been present for approximately three days and are worse after intercourse. She denies fever, chills, abdominal pain, or abnormal vaginal bleeding. Patient reports a history of recurrent yeast infections, with the last episode occurring approximately six months ago. She denies any known allergies. Current medications include an oral contraceptive. Social history is negative for tobacco use; occasional alcohol use is reported. Objective: Pelvic examination reveals erythema and edema of the vulva and vagina. Thick, white, adherent discharge is noted in the vaginal vault. Microscopic examination of a wet mount preparation reveals budding yeast and pseudohyphae, confirming the diagnosis of Vulvovaginal Candidiasis (VVC). No cervical motion tenderness or adnexal masses are palpated. Vital signs are within normal limits. Assessment: Vulvovaginal Candidiasis (Yeast Infection). Differential diagnoses considered include Bacterial Vaginosis and Trichomoniasis, but these were ruled out based on clinical presentation and microscopic findings. ICD-10 code B37.3 is assigned. Plan: Patient was educated on the diagnosis and treatment of yeast infections. She was prescribed Fluconazole 150mg oral tablet, single dose. Patient counseling included discussion of preventative measures such as avoiding tight-fitting clothing, maintaining good hygiene practices, and considering probiotic use. Follow-up is recommended if symptoms do not resolve within one week. Patient was provided with information on vulvovaginal candidiasis treatment, yeast infection symptoms, vaginal discharge causes, and candidiasis diagnosis. Information regarding prescription drug costs and over-the-counter antifungal treatment options was also discussed.